One study proposed that SHH inhibitors could be effective in treating ETMRs, based on the capability of forming tumors with ETMR-like histology using activation of the WNT and SHH pathways and a general upregulation of the SHH pathway in ETMRs [98]. The gene discussed is SHH; the disease is ependymoblastoma.